Immunosafety evaluation in Juvenile Göttingen Minipigs

Although an extrapolation from the clinical experience in adults can often be considered to support the pediatric use for most pharmaceutical compounds, differences in safety profiles between adult and pediatric patients can be observed. The developing immune system may be affected due to exaggerate...

Full description

Bibliographic Details
Main Authors: Linda Allais, Alicia Perbet, Fabienne Condevaux, Jean-Paul Briffaux, Marc Pallardy
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Journal of Immunotoxicology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/1547691X.2022.2088904
_version_ 1818242473829335040
author Linda Allais
Alicia Perbet
Fabienne Condevaux
Jean-Paul Briffaux
Marc Pallardy
author_facet Linda Allais
Alicia Perbet
Fabienne Condevaux
Jean-Paul Briffaux
Marc Pallardy
author_sort Linda Allais
collection DOAJ
description Although an extrapolation from the clinical experience in adults can often be considered to support the pediatric use for most pharmaceutical compounds, differences in safety profiles between adult and pediatric patients can be observed. The developing immune system may be affected due to exaggerated pharmacological or non-expected effects of a new drug. Toxicology studies in juvenile animals could therefore be required to better evaluate the safety profile of any new pharmaceutical compound targeting the pediatric population. The Göttingen minipig is now considered a useful non-rodent species for non-clinical safety testing of human pharmaceuticals. However, knowledge on the developing immune system in juvenile minipigs is still limited. The objective of the work reported here was to evaluate across-age proportions of main immune cells circulating in blood or residing in lymphoid organs (thymus, spleen, lymph nodes) in Göttingen Minipigs. In parallel, the main immune cell populations from healthy and immunocompromised piglets were compared following treatment with cyclosporin A (CsA) at 10 mg/kg/day for 4 wk until weaning. The study also assessed functionality of immune responses using an in-vivo model after “Keyhole limpet hemocyanin” (KLH) immunization and an ex-vivo lymph proliferation assay after stimulation with Concanavalin A. The results demonstrated variations across age in circulating immune cell populations including CD21+ B-cells, αβ-T- and γδ-T-cells, NK cells, and monocytes. CsA-induced changes in immune functions were only partially recovered by 5 mo after the end of treatment, whereas the immune cell populations affected by the treatment returned to normal levels in animals of the same age. Taken together, the study here shows that in this model, the immune function endpoints were more sensitive than the immunophenotyping endpoints.
first_indexed 2024-12-12T13:45:48Z
format Article
id doaj.art-791ac427c2544ba5a394ee9ffe37d225
institution Directory Open Access Journal
issn 1547-691X
1547-6901
language English
last_indexed 2024-12-12T13:45:48Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Immunotoxicology
spelling doaj.art-791ac427c2544ba5a394ee9ffe37d2252022-12-22T00:22:41ZengTaylor & Francis GroupJournal of Immunotoxicology1547-691X1547-69012022-12-01191415210.1080/1547691X.2022.2088904Immunosafety evaluation in Juvenile Göttingen MinipigsLinda Allais0Alicia Perbet1Fabienne Condevaux2Jean-Paul Briffaux3Marc Pallardy4Charles River Laboratories France Safety Assessment, Saint-Germain-Nuelles, FranceCharles River Laboratories France Safety Assessment, Saint-Germain-Nuelles, FranceCharles River Laboratories France Safety Assessment, Saint-Germain-Nuelles, FranceCharles River Laboratories France Safety Assessment, Saint-Germain-Nuelles, FranceInserm, Inflammation, Microbiome, and Immunosurveillance, Université Paris-Saclay, Châtenay-Malabry, FranceAlthough an extrapolation from the clinical experience in adults can often be considered to support the pediatric use for most pharmaceutical compounds, differences in safety profiles between adult and pediatric patients can be observed. The developing immune system may be affected due to exaggerated pharmacological or non-expected effects of a new drug. Toxicology studies in juvenile animals could therefore be required to better evaluate the safety profile of any new pharmaceutical compound targeting the pediatric population. The Göttingen minipig is now considered a useful non-rodent species for non-clinical safety testing of human pharmaceuticals. However, knowledge on the developing immune system in juvenile minipigs is still limited. The objective of the work reported here was to evaluate across-age proportions of main immune cells circulating in blood or residing in lymphoid organs (thymus, spleen, lymph nodes) in Göttingen Minipigs. In parallel, the main immune cell populations from healthy and immunocompromised piglets were compared following treatment with cyclosporin A (CsA) at 10 mg/kg/day for 4 wk until weaning. The study also assessed functionality of immune responses using an in-vivo model after “Keyhole limpet hemocyanin” (KLH) immunization and an ex-vivo lymph proliferation assay after stimulation with Concanavalin A. The results demonstrated variations across age in circulating immune cell populations including CD21+ B-cells, αβ-T- and γδ-T-cells, NK cells, and monocytes. CsA-induced changes in immune functions were only partially recovered by 5 mo after the end of treatment, whereas the immune cell populations affected by the treatment returned to normal levels in animals of the same age. Taken together, the study here shows that in this model, the immune function endpoints were more sensitive than the immunophenotyping endpoints.https://www.tandfonline.com/doi/10.1080/1547691X.2022.2088904Developing immune systemjuvenileGöttingen minipigimmunotoxicology
spellingShingle Linda Allais
Alicia Perbet
Fabienne Condevaux
Jean-Paul Briffaux
Marc Pallardy
Immunosafety evaluation in Juvenile Göttingen Minipigs
Journal of Immunotoxicology
Developing immune system
juvenile
Göttingen minipig
immunotoxicology
title Immunosafety evaluation in Juvenile Göttingen Minipigs
title_full Immunosafety evaluation in Juvenile Göttingen Minipigs
title_fullStr Immunosafety evaluation in Juvenile Göttingen Minipigs
title_full_unstemmed Immunosafety evaluation in Juvenile Göttingen Minipigs
title_short Immunosafety evaluation in Juvenile Göttingen Minipigs
title_sort immunosafety evaluation in juvenile gottingen minipigs
topic Developing immune system
juvenile
Göttingen minipig
immunotoxicology
url https://www.tandfonline.com/doi/10.1080/1547691X.2022.2088904
work_keys_str_mv AT lindaallais immunosafetyevaluationinjuvenilegottingenminipigs
AT aliciaperbet immunosafetyevaluationinjuvenilegottingenminipigs
AT fabiennecondevaux immunosafetyevaluationinjuvenilegottingenminipigs
AT jeanpaulbriffaux immunosafetyevaluationinjuvenilegottingenminipigs
AT marcpallardy immunosafetyevaluationinjuvenilegottingenminipigs